Posts Tagged ‘platelet rich plasma injections’

New Research from Orthohealing Center’s Dr Steven Sampson & Dr Danielle Aufiero on the world’s largest placebo controlled PRP trial on tennis elbow, presented at the AAOS in Chicago IL.

Thursday, March 28th, 2013 by Steven Sampson D.O.

Platelet-Rich Plasma Significantly Improves Clinical Outcomes in Patients with Chronic Tennis Elbow:
sampson mishra pic 225x300 New Research from Orthohealing Center’s Dr Steven Sampson & Dr Danielle Aufiero on the world’s largest placebo controlled PRP trial on tennis elbow, presented at the AAOS in Chicago IL.A Double-Blind, Prospective, Multicenter, Controlled Trial of 230 Patients

Allan K. Mishra,  MD; Nebojsa V. Skrepnik, MD, PhD; Scott G. Edwards, MD; Grant L. Jones, MD; Steven Sampson, DO; Doug A. Vermillion, MD; Matthew L. Ramsey, MD; David C. Karli, MD, MBA; Arthur C. Rettig, MD

Dr Steven Sampson travelled to Chicago for the world’s largest gathering of orthopaedic surgeons (AAOS) as a Principal Investigator in the world’s largest placebo controlled PRP trial.  The study was a randomized, double-blind, multi-center controlled trial of 230 patients.  Patients received needling of their elbow tendons with and without PRP.  At 24 weeks the PRP patients reports a 71.5% improvement in their pain compared to 56.1 in the control group. (P = 0.027)  Patients treated with PRP also had less elbow tenderness at each follow up point. Overall, 84% of the PRP patients were successfully treated compared to 68.3% of the control group. (P = 0.012)

84% of patients with chronic tennis elbow who had failed other non-operative treatments were successfully treated using platelet-rich plasma (PRP) in a large randomized trial.

There are now over 340 patients who have been treated confirming the value of PRP as a treatment for chronic tennis elbow.  Importantly, there is also a decade long experience using PRP with an excellent safety profile.  PRP with this newly released data can now be confidently used for chronic tennis elbow patients prior to considering surgical intervention.

The results will be presented by Dr. Allan K. Mishra at TOBI 4th Annual PRP & Regenerative Medicine Symposium, June 7-8, 2013 in Los Angeles. Event details and registration online at www.prpseminar.com.

This study took 6 years to produce and validate the findings we have seen in our clinics for years. More and more robust trials are coming to further clarify the role for PRP and regenerative procedures in the near future.

View Abstract: PRPseminar.com

For more of the latest PRP research and clinical experience, plus networking with field leaders, attend The Orthobiologic Institute (TOBI) 4th Annual PRP & Regenerative Medicine Symposium, June 7-8, 2013 in Los Angeles. Details and registration at www.prpseminar.com. Early Rates through March 31st – Register Now!

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

New Review article suggests positive effects of PRP Platelet Rich Plasma injections for knee osteoarthritis. More studies needed.

Thursday, November 15th, 2012 by Steven Sampson D.O.

A recent review of multiple studies supports Platelet-Rich Plasma use as an alternative method in the treatment of Osteoarthritis. PRP is simple, minimally invasive, and clinically safe with no serious side effect reported by the patients. It uses your body’s own growth factors (naturally occurring substances) that favor the healing process and tissue regeneration. One study showed significant clinical improvement at one-year follow-up when compared to the pre-therapy visit. Another study showed that patients were satisfied 2 years after receiving PRP injections. In another study PRP therapy was more efficacious and long lasting than Hyaluronic acid injections in reducing pain and symptoms. Additionally, there was evidence supporting PRP’s ability to improve pain and knee function in patients, especially in younger men.  Each year more and more studies are emerging showing the positive effects of PRP Platelet Rich Plasma for osteoarthritis to target the disease process rather than masking the symptoms and to avoid further cartilage damage.

Steven Sampson D.O.

Founder of the Orthohealing Center, Dr. Sampson is a recognized expert on orthobiologics and regenerative medicine. He lectures internationally and spearheads OHC’s clinical research efforts. Dr. Sampson is a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA, and is a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

David Ortiz of the Boston Red Sox to Receive Platelet Rich Plasma (PRP) Therapy for his Achilles Injury with Hopes of Saving His Season

Thursday, August 30th, 2012 by Beny Charchian, M.D., M.S.

David Ortiz of the Boston Red Sox is scheduled to receive a Platelet Rich Plasma (PRP) injection to his strained right Achilles’ tendon – the same injury which forced him to miss 35 games. Ortiz is no stranger to the beneficial effects of PRP. He had a PRP injection to his right knee in 2007 which he said helped him recover from surgery, so when it was suggested for his current achilles injury he was eager to undergo the procedure again. According to Boston.com, ”I had that done before and I believe in it big time,” Ortiz said of the PRP procedure.

PRP is simple procedure which uses a patient’s own blood to treat an injured area naturally. After the blood is drawn, it is placed in a centrifuge to concentrate the platelets which are rich in growth factors. Studies have shown these growth factors have promise in treating a wide array of injuries to muscles, tendons, ligaments, and joints. Once used only by elite athletes, these injections are now available to anyone suffering from painful injuries or arthritic joints.

 

Beny Charchian, M.D., M.S.

Dr. Charchian specializes in Interventional Pain Management integrating Fluoroscopy (live X-Ray), in addition to treating an array of spine and joint disorders non-surgically. He has extensive training in electrodiagnostic studies to evaluate nerve injuries. He completed a Pain Medicine Fellowship at UCLA and is currently a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA as well as a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

Italian Study Endorses the Use of Platelet Rich Plasma for Tissue Regeneration in Degenerative Disorders of the Knee

Tuesday, March 13th, 2012 by Beny Charchian, M.D., M.S.

A new study out of Italy recently published in Blood Transfusion outlines the benefits of platelet-derived growth factors for improving tissue regeneration in the field of non-surgical orthopedic care.

 Twenty-seven patients, aged between 18 and 81 years, with a diagnosis of degenerative joint disease lasting for more than 1 year were treated. The patients were divided into two groups, one with arthritis of the knee, the other with degenerative cartilage disease of the knee. Both groups were treated with a cycle of three platelet-rich plasma injections at weekly intervals.

 Pain rating scales were used before treatment, 7 days after treatment, and again 6 months after treatment.  Both groups improved after the initial treatment and there was a further improvement after 6 months of follow-up. 

 The study references Dr. Steven Sampson’s pilot trial on PRP for knee arthritis.  Our practice offers a nearly identical protocol which utilizes a swiss based PRP device to isolate the platelets.

Again and again, we see the benefits of platelet rich plasma for a multitude of degenerative joint conditions endorsed by research studies from all over the world!

Beny Charchian, M.D., M.S.

Dr. Charchian specializes in Interventional Pain Management integrating Fluoroscopy (live X-Ray), in addition to treating an array of spine and joint disorders non-surgically. He has extensive training in electrodiagnostic studies to evaluate nerve injuries. He completed a Pain Medicine Fellowship at UCLA and is currently a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA as well as a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

New Study Indicates Knee Replacement Data Lacking for Long-Term Safety and Effectiveness

Tuesday, March 6th, 2012 by Beny Charchian, M.D., M.S.

Knee replacement surgery has long helped many patients with severe arthritis, but a new study published online today, March 6th 2012, in the Lancet reveals that not enough is known about patient outcomes or the effectiveness of various implants, and consensus is lacking about the precise indications for the procedure.

The authors, based in the United Kingdom, Sweden, and Australia, write that surgeons need improved decision-making as more and more possible candidates for new knees are younger than 55 years — a group that has a higher rate of revision or follow-up surgery. On another problematic note, some patients undergo the operation despite having good functional ability and only mild pain beforehand.  The article, based on a literature review going back to 1970, raises doubts about the evidence on orthopaedic joint implant safety and effectiveness.

Andrew Carr, lead author of the Lancet article, writes that the number of total knee replacements (TKRs) per 100,000 people in the United States increased more than seven fold from 1971 to 2008, for a total of more than 650,000 procedures in 2008.

“No clear consensus exists within the surgical community about exact indications, particularly severity of preoperative symptoms, obesity, and age,” Dr. Carr and coauthors write. They point to a task force organized by the Osteoarthritis Research Society International and a rheumatology organization that found that “pain, function, and radiographic severity are not associated with a surgeon’s recommendation for knee replacement.”

In addition to recommending better patient selection and better reporting of outcomes, the authors also call for new strategies to treat early-stage osteoarthritis in younger patients that will “avoid the need for major surgery altogether.”

The Orthohealing Center is aware of the growing trend on the part of patients and physicians to treat arthritic joint conditions involving the knee, shoulder, shoulder, ankle, neck, and back conservatively and is proud to offer a wide array of non-surgical treatment options including steroid injections, viscosupplementation, epidural steroid injections, radiofrequency ablation, and platelet rich plasma injections.

Beny Charchian, M.D., M.S.

Dr. Charchian specializes in Interventional Pain Management integrating Fluoroscopy (live X-Ray), in addition to treating an array of spine and joint disorders non-surgically. He has extensive training in electrodiagnostic studies to evaluate nerve injuries. He completed a Pain Medicine Fellowship at UCLA and is currently a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA as well as a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

Los Angeles Times Report on Keeping your Low Back Pain-Free

Tuesday, February 28th, 2012 by Beny Charchian, M.D., M.S.

An article published today in the Los Angeles Times outlines the low back pain epidemic and tips on how to keep your low back pain-free.

A 2009 study in Archives of Internal Medicine found that the prevalence of chronic, impairing low back pain rose from 3.9% of adults in 1992 to 10.2% in 2006. And a 2006 study from the National Institute of Arthritis and Musculoskeletal and Skin Diseases says that lower-back pain is the No. 2 reason why Americans see a doctor, second only to the common cold.

Stu McGill, a professor of spine biomechanics at the University of Waterloo in Ontario, says the majority of low-back pain stems from the cumulative damage caused by bending forward at the waist. That motion causes the vertebrae toward the base of the spine to pinch together; if you’re not careful about maintaining proper form, it can lead to problems like herniated disks.

Core strengthening is often times the intial step in treating low back pain and preventing further recurrences.  “Pain is just a symptom, and we want to find the source,” states Craig Liebenson, who spent four years as team chiropractor for the L.A. Clippers and is director of Los Angeles Sports and Spine.  “Healthy core function helps to reduce back pain by providing a margin of error when lifting, bending or twisting”.  These active treatments require more effort than passive treatments such as chiropractic manipulation or massage therapy. “The most important thing is showing people what to do for themselves,” Liebenson said.

Dr. Beny Charchian, a low back pain and interventional spine specialist at the Orthohealing Center is proud to work with Dr. Liebenson and other leaders in the community to provide an individualized rehabilitation program in combination with minimally invasive injections such as epidural steroid injections, facet joint injections, platelet rich plasma injections, and radiofrequency ablation to provide pain relief and help patients regain thier active lifestyles!

Beny Charchian, M.D., M.S.

Dr. Charchian specializes in Interventional Pain Management integrating Fluoroscopy (live X-Ray), in addition to treating an array of spine and joint disorders non-surgically. He has extensive training in electrodiagnostic studies to evaluate nerve injuries. He completed a Pain Medicine Fellowship at UCLA and is currently a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA as well as a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.